Translational prospects for human induced pluripotent stem cells
- PMID: 20632855
- DOI: 10.2217/rme.10.39
Translational prospects for human induced pluripotent stem cells
Abstract
The pace of research on human induced pluripotent stem (iPS) cells is frantic worldwide, based on the enormous therapeutic potential of patient-specific pluripotent cells free of the ethical and political issues that plagued human embryonic stem cell research. iPS cells are now relatively easy to isolate from somatic cells and reprogramming can be accomplished using nonmutagenic technologies. Access to iPS cells is already paying dividends in the form of new disease-in-a-dish models for drug discovery and as scalable sources of cells for toxicology. For translation of cell therapies, the major advantage of iPS cells is that they are autologous, but for many reasons, perfect immunologic tolerance of iPS-based grafts should not be assumed. This article focuses on the functional identity of iPS cells, anticipated safety and technical issues in their application, as well as a survey of the progress likely to be realized in clinical applications in the next decade.
Similar articles
-
Regulatory considerations for the development of autologous induced pluripotent stem cell therapies.Regen Med. 2010 Jul;5(4):569-79. doi: 10.2217/rme.10.55. Regen Med. 2010. PMID: 20632860
-
How induced pluripotent stem cells are redefining personalized medicine.Gene. 2013 May 10;520(1):1-6. doi: 10.1016/j.gene.2013.02.037. Epub 2013 Mar 5. Gene. 2013. PMID: 23470844 Review.
-
Uncertain translation, uncertain benefit and uncertain risk: ethical challenges facing first-in-human trials of induced pluripotent stem (ips) cells.Bioethics. 2013 Feb;27(2):89-96. doi: 10.1111/j.1467-8519.2011.01896.x. Epub 2011 Jul 4. Bioethics. 2013. PMID: 21726264
-
A commentary on iPS cells: potential applications in autologous transplantation, study of illnesses and drug screening.J Cell Physiol. 2014 Feb;229(2):148-52. doi: 10.1002/jcp.24437. J Cell Physiol. 2014. PMID: 23881704 Review.
-
Induced pluripotent stem cells: opportunities as research and development tools in 21st century drug discovery.Regen Med. 2010 Jul;5(4):557-68. doi: 10.2217/rme.10.36. Regen Med. 2010. PMID: 20632859
Cited by
-
Process-based expansion and neural differentiation of human pluripotent stem cells for transplantation and disease modeling.J Neurosci Res. 2013 Oct;91(10):1247-62. doi: 10.1002/jnr.23245. Epub 2013 Jul 26. J Neurosci Res. 2013. PMID: 23893392 Free PMC article.
-
Characteristic analyses of a neural differentiation model from iPSC-derived neuron according to morphology, physiology, and global gene expression pattern.Sci Rep. 2017 Sep 25;7(1):12233. doi: 10.1038/s41598-017-12452-x. Sci Rep. 2017. PMID: 28947763 Free PMC article.
-
Regenerating functional heart tissue for myocardial repair.Cell Mol Life Sci. 2012 Aug;69(16):2635-56. doi: 10.1007/s00018-012-0942-4. Epub 2012 Mar 3. Cell Mol Life Sci. 2012. PMID: 22388688 Free PMC article. Review.
-
Efficient Isolation and Enrichment of Mesenchymal Stem Cells from Human Embryonic Stem Cells by Utilizing the Interaction between Integrin α5β1 and Fibronectin.Adv Sci (Weinh). 2020 Jul 19;7(17):2001365. doi: 10.1002/advs.202001365. eCollection 2020 Sep. Adv Sci (Weinh). 2020. PMID: 32995130 Free PMC article.
-
Common pitfalls of stem cell differentiation: a guide to improving protocols for neurodegenerative disease models and research.Cell Mol Life Sci. 2016 Oct;73(19):3693-709. doi: 10.1007/s00018-016-2265-3. Epub 2016 May 6. Cell Mol Life Sci. 2016. PMID: 27154043 Free PMC article. Review.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
